Intuitive Surgical (ISRG) Earning Somewhat Positive Press Coverage, Report Finds

Media stories about Intuitive Surgical (NASDAQ:ISRG) have trended somewhat positive on Sunday, according to Accern. The research group identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Intuitive Surgical earned a coverage optimism score of 0.06 on Accern’s scale. Accern also gave media headlines about the medical equipment provider an impact score of 45.8149253629836 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

These are some of the news stories that may have effected Accern Sentiment’s analysis:

Shares of Intuitive Surgical (ISRG) opened at $416.96 on Friday. Intuitive Surgical has a 1-year low of $232.24 and a 1-year high of $452.00. The firm has a market cap of $46,719.53, a P/E ratio of 73.41, a P/E/G ratio of 4.91 and a beta of 0.50.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, January 25th. The medical equipment provider reported $2.54 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.27 by $0.27. The company had revenue of $892.40 million during the quarter, compared to analysts’ expectations of $866.54 million. Intuitive Surgical had a net margin of 21.09% and a return on equity of 19.93%. The firm’s revenue was up 17.9% compared to the same quarter last year. During the same quarter last year, the company posted $2.03 EPS. research analysts expect that Intuitive Surgical will post 7.93 earnings per share for the current year.

A number of equities analysts recently commented on the stock. Wells Fargo & Co reissued a “buy” rating on shares of Intuitive Surgical in a research note on Monday, October 16th. Wedbush reaffirmed a “buy” rating on shares of Intuitive Surgical in a research report on Tuesday, October 10th. Zacks Investment Research raised Intuitive Surgical from a “hold” rating to a “buy” rating and set a $418.00 price target on the stock in a research report on Wednesday, October 25th. BidaskClub downgraded Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, December 12th. Finally, Goldman Sachs Group reissued a “buy” rating on shares of Intuitive Surgical in a research report on Saturday, November 18th. One research analyst has rated the stock with a sell rating, six have issued a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. Intuitive Surgical has a consensus rating of “Buy” and an average target price of $409.40.

In related news, Director Lonnie M. Smith sold 18,000 shares of Intuitive Surgical stock in a transaction on Tuesday, January 30th. The shares were sold at an average price of $428.68, for a total transaction of $7,716,240.00. Following the sale, the director now directly owns 511,410 shares in the company, valued at approximately $219,231,238.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Curet Myriam sold 262 shares of Intuitive Surgical stock in a transaction on Tuesday, January 30th. The stock was sold at an average price of $431.50, for a total transaction of $113,053.00. Following the sale, the executive vice president now owns 2,152 shares in the company, valued at $928,588. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 41,847 shares of company stock valued at $17,225,711. Corporate insiders own 2.20% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another domain, it was stolen and reposted in violation of US and international copyright and trademark law. The original version of this piece can be accessed at https://www.dispatchtribunal.com/2018/02/04/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-intuitive-surgical-isrg-share-price.html.

About Intuitive Surgical

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Insider Buying and Selling by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply